RETINAL DEGENERATION
Clinical trials for RETINAL DEGENERATION explained in plain language.
Never miss a new study
Get alerted when new RETINAL DEGENERATION trials appear
Sign up with your email to follow new studies for RETINAL DEGENERATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Gene therapy injection aims to save sight in rare genetic disease
Disease control Not yet recruitingThis early-stage trial tests a single injection of AXV-101 gene therapy into one eye of 12 children and teens (ages 4-17) with Bardet-Biedl syndrome type 1, a rare genetic condition that causes progressive vision loss. The main goal is to check safety and find the right dose, whi…
Matched conditions: RETINAL DEGENERATION
Phase: EARLY_PHASE1 • Sponsor: Axovia Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
Magnetic pulses to the brain may help the blind see again
Symptom relief Not yet recruitingThis clinical trial tests whether transcranial magnetic stimulation (TMS) can restore vision in adults with severe retinal degeneration. Over 100 participants will receive either real TMS or a sham (fake) treatment for five days, and their eyesight will be checked up to a year la…
Matched conditions: RETINAL DEGENERATION
Phase: NA • Sponsor: Shanghai High Myopia Study Group • Aim: Symptom relief
Last updated Jun 27, 2026 09:08 UTC